This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jun 2;379(9831):2030-1.

doi: 10.1016/S0140-6736(12)60406-1. Epub 2012 May 3.

Antipsychotic drugs for prevention of relapse

Jim van Os¹, Oliver D Howes

Affiliations

Affiliation

¹ Department of Psychiatry and Psychology, Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, EURON, 6200 MD Maastricht, Netherlands. j.vanos@maastrichtuniversity.nl

PMID: 22560608
DOI: 10.1016/S0140-6736(12)60406-1

Comment

Antipsychotic drugs for prevention of relapse

Jim van Os et al. Lancet. 2012.

. 2012 Jun 2;379(9831):2030-1.

doi: 10.1016/S0140-6736(12)60406-1. Epub 2012 May 3.

Authors

Jim van Os¹, Oliver D Howes

Affiliation

¹ Department of Psychiatry and Psychology, Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, EURON, 6200 MD Maastricht, Netherlands. j.vanos@maastrichtuniversity.nl

PMID: 22560608
DOI: 10.1016/S0140-6736(12)60406-1

No abstract available

PubMed Disclaimer

Comment on

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM. Leucht S, et al. Lancet. 2012 Jun 2;379(9831):2063-71. doi: 10.1016/S0140-6736(12)60239-6. Epub 2012 May 3. Lancet. 2012. PMID: 22560607

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information